Chlamydia muridarum infection of macrophages elicits bactericidal nitric oxide production via reactive oxygen species and cathepsin B

Infection and Immunity

Volumn 83, Issue 8, 2015, Pages 3164-3175

  Rajaram, Krithika ^a,c   Nelson, David E ^b  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CATHEPSIN B; HYDROXYL RADICAL; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 2;

ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; CELL DEATH; CELL DIVISION; CELL SURVIVAL; CHLAMYDIA MURIDARUM; CHLAMYDIASIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; ENZYME INDUCTION; HOST CELL; HOST PATHOGEN INTERACTION; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PHAGOLYSOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; ENZYMOLOGY; GENETICS; HUMAN; IMMUNOLOGY; MICROBIOLOGY; PHYSIOLOGY;

ANIMALS; CATHEPSIN B; CELL LINE; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; HUMANS; INTERLEUKIN-6; MACROPHAGES; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; REACTIVE OXYGEN SPECIES;

EID: 84937800323     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00382-15     Document Type: Article

References (62)

1. Rusconi B, Greub G. 2011. Chlamydiales and the innate immune response:friend or foe? FEMS Immunol Med Microbiol 61:231-244. http://dx.doi.org/10.1111/j.1574-695X.2010.00772.x.
2. Darville T, Hiltke TJ. 2010. Pathogenesis of genital tract disease due to Chlamydia trachomatis. J Infect Dis 201(Suppl 2):S114-S125.
3. Miyairi I, Laxton JD, Wang X, Obert CA, Tatireddigari VRRA, van Rooijen N, Hatch TP, Byrne GI. 2011. Chlamydia psittaci genetic variants differ in virulence by modulation of host immunity. J Infect Dis 204:654-663. http://dx.doi.org/10.1093/infdis/jir333.
4. Qiu H, Fan Y, Joyee AG, Wang S, Han X, Bai H, Jiao L, Van Rooijen N, Yang X. 2008. Type I IFNs enhance susceptibility to Chlamydia muridarum lung infection by enhancing apoptosis of local macrophages. J Immunol 181:2092-2102. http://dx.doi.org/10.4049/jimmunol.181.3.2092.
5. Rothfuchs AG, Kreuger MR, Wigzell H, Rottenberg ME. 2004. Macrophages, CD4(+) or CD8(+) cells are each sufficient for protection against Chlamydia pneumoniae infection through their ability to secrete IFNgamma. J Immunol 172:2407-2415. http://dx.doi.org/10.4049/jimmunol .172.4.2407.
6. Sun HS, Eng EWY, Jeganathan S, Sin ATW, Patel PC, Gracey E, Inman RD, Terebiznik MR, Harrison RE. 2012. Chlamydia trachomatis vacuole maturation in infected macrophages. J Leukoc Biol 92:815-827. http://dx .doi.org/10.1189/jlb.0711336.
7. O'Donnell H, Pham OH, Li LX, Atif SM, Lee SJ, Ravesloot MM, Stolfi JL, Nuccio S-P, Broz P, Monack DM, Baumler AJ, McSorley SJ. 2014. Toll-like receptor and inflammasome signals converge to amplify the innate bactericidal capacity of T helper 1 cells. Immunity 40:213-224. http://dx.doi.org/10.1016/j.immuni.2013.12.013.
8. Kuo CC. 1978. Cultures of Chlamydia trachomatis in mouse peritoneal macrophages: factors affecting organism growth. Infect Immun 20:439-445.
9. Yong EC, Chi EY, Kuo CC. 1987. Differential antimicrobial activity of human mononuclear phagocytes against the human biovars of Chlamydia trachomatis. J Immunol 139:1297-1302.
10. Manor E, Schmitz E, Sarov I. 1993. TNF and PGE(2) in human monocyte-derived macrophages infected with C. tracohmatis. Mediators Inflamm 2:367-371. http://dx.doi.org/10.1155/S0962935193000511.
11. Gold ES, Simmons RM, Petersen TW, Campbell LA, Kuo CC, Aderem A. 2004. Amphiphysin IIm is required for survival of Chlamydia pneumoniae in macrophages. J Exp Med 200:581-586. http://dx.doi.org/10.1084/jem.20040546.
12. Wyrick PB, Brownridge EA. 1978. Growth of Chlamydia psittaci in macrophages. Infect Immun 19:1054-1060.
13. Smith EB, Custer RP. 1950. The histopathology of Lymphogranuloma venereum. J Urol 63:546-563.
14. de Vries HJC, Smelov V, Middelburg JG, Pleijster J, Speksnijder AG, Morre SA. 2009. Delayed microbial cure of Lymphogranuloma venereum proctitis with doxycycline treatment. Clin Infect Dis 48:E53-E56. http://dx.doi.org/10.1086/597011.
15. Hoymans VY, Bosmans JM, Ieven MM, Vrints CJ. 2007. Chlamydia pneumoniae-based atherosclerosis: a smoking gun. Acta Cardiol 62:565-571. http://dx.doi.org/10.2143/AC.62.6.2024015.
16. Hammerschlag MR, Kohlhoff SA, Darville T. 2009. Chlamydia pneumoniae and Chlamydia trachomatis, p 27-52. In Fratamico PM, Smith JL, Brogden KA (ed), Sequelae and long-term consequences of infectious diseases. ASM Press, Washington, DC.
17. Fields KA, McCormack R, de Armas LR, Podack ER. 2013. Perforin-2 restricts growth of Chlamydia trachomatis in macrophages. Infect Immun 81:3045-3054. http://dx.doi.org/10.1128/IAI.00497-13.
18. Ma Martinez FO, Gordon S. 2014. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep 6:13. http://dx .doi.org/10.12703/P6-13.
19. Rottenberg ME, Gigliotti-Rothfuchs A, Wigzell H. 2002. The role of IFN-gamma in the outcome of chlamydial infection. Curr Opin Immunol 14:444-451. http://dx.doi.org/10.1016/S0952-7915(02)00361-8.
20. Rothermel CD, Rubin BY, Murray HW. 1983. Gamma-interferon is the factor in lymphokine that activates human macrophages to inhibit intracellular Chlamydia psittaci replication. J Immunol 131:2542-2544.
21. Shemer Y, Sarov I. 1985. Inhibition of growth of Chlamydia trachomatis by human gamma interferon. Infect Immun 48:592-596.
22. Gracey E, Inman RD. 2012. Chlamydia-induced ReA: immune imbalances and persistent pathogens. Nat Rev Rheumatol 8:55-59. http://dx.doi .org/10.1038/nrrheum.2011.173.
23. Gracey E, Lin A, Akram A, Chiu B, Inman RD. 2013. Intracellular survival and persistence of Chlamydia muridarum Is determined by macrophage polarization. PLoS One 8:e69421. http://dx.doi.org/10.1371/journal.pone.0069421.
24. Kuo CC. 1978. Immediate cytotoxicity of Chlamydia trachomatis for mouse peritoneal macrophages. Infect Immun 20:613-618.
25. Caldwell HD, Kromhout J, Schachter J. 1981. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun 31:1161-1176.
26. Jayarapu K, Kerr MS, Katschke A, Johnson RM. 2009. Chlamydia muridarum-specific CD4 T-cell clones recognize infected reproductive tract epithelial cells in an interferon-dependent fashion. Infect Immun 77:4469-4479. http://dx.doi.org/10.1128/IAI.00491-09.
27. Zhang DJ, Yang X, Berry J, Shen CX, McClarty G, Brunham RC. 1997. DNA vaccination with the major outer-membrane protein gene induces acquired immunity to Chlamydia trachomatis (mouse pneumonitis) infection. J Infect Dis 176:1035-1040. http://dx.doi.org/10.1086/516545.
28. Schneider CA, Rasband WS, Eliceiri KW. 2012. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671-675. http://dx.doi.org/10.1038/nmeth.2089.
29. Roshick C, Wood H, Caldwell HD, McClarty G. 2006. Comparison of gamma interferon-mediated antichlamydial defense mechanisms in human and mouse cells. Infect Immun 74:225-238. http://dx.doi.org/10.1128/IAI.74.1.225-238.2006.
30. Arango Duque G, Descoteaux A. 2014. Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol 5:491. http://dx.doi.org/10.3389/fimmu.2014.00491.
31. Dessus-Babus S, Knight ST, Wyrick PB. 2000. Chlamydial infection of polarized HeLa cells induces PMN chemotaxis but the cytokine profile varies between disseminating and non-disseminating strains. Cell Microbiol 2:317-327. http://dx.doi.org/10.1046/j.1462-5822.2000.00058.x.
32. O'Connell CM, Ionova IA, Quayle AJ, Visintin A, Ingalls RR. 2006. Localization of TLR2 and MyD88 to Chlamydia trachomatis inclusions-evidence for signaling by intracellular TLR2 during infection with an obligate intracellular pathogen. J Biol Chem 281:1652-1659. http://dx.doi .org/10.1074/jbc.M510182200.
33. Rothfuchs AG, Gigliotti D, Palmblad K, Andersson U, Wigzell H, Rottenberg ME. 2001. IFN-alpha beta-dependent, IFN-gamma secretion by bone-marrow-derived macrophages controls an intracellular bacterial infection. J Immunol 167:6453-6461. http://dx.doi.org/10.4049/jimmunol.167.11.6453.
34. Da Costa CUP, Wantia N, Kirschning CJ, Busch DH, Rodriguez N, Wagner H, Miethke T. 2004. Heat shock protein 60 from Chlamydia pneumoniae elicits an unusual set of inflammatory responses via Toll-like receptor 2 and 4 in vivo. Eur J Immunol 34:2874-2884. http://dx.doi.org /10.1002/eji.200425101.
35. Ingalls RR, Rice PA, Qureshi N, Takayama K, Lin JS, Golenbock DT. 1995. The inflammatory cytokine response to Chlamydia trachomatis infection is endotoxin mediated. Infect Immun 63:3125-3130.
36. Yao SY, Ljunggren-Rose A, Stratton CW, Mitchell WM, Sriram S. 2001. Regulation by IFN-beta of inducible nitric oxide synthase and interleukin-12/p40 in murine macrophages cultured in the presence of Chlamydia pneumoniae antigens. J Interferon Cytokine Res 21:137-146. http://dx.doi .org/10.1089/107999001750133131.
37. Zhang Y, Wang H, Ren J, Tang X, Jing Y, Xing D, Zhao G, Yao Z, Yang X, Bai H. 2012. IL-17A synergizes with IFN-gamma to upregulate iNOS and NO production and inhibit chlamydial growth. PLoS One 7:e39214. http://dx.doi.org/10.1371/journal.pone.0039214.
38. Bae YS, Oh H, Rhee SG, Do Yoo Y. 2011. Regulation of reactive oxygen species generation in cell signaling. Mol Cells 32:491-509. http://dx.doi .org/10.1007/s10059-011-0276-3.
39. Parker NB, Berger EM, Curtis WE, Muldrow ME, Linas SL, Repine JE. 1985. Hydrogen peroxide causes dimethylthiourea consumption while hydroxyl radical causes DMSO consumption in vitro. J Free Radic Biol Med 1:415-420. http://dx.doi.org/10.1016/0748-5514(85)90155-2.
40. Boer R, Ulrich WR, Klein T, Mirau B, Haas S, Baur I. 2000. The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes. Mol Pharmacol 58:1026-1034.
41. Shimada K, Crother TR, Karlin J, Chen S, Chiba N, Ramanujan VK, Vergnes L, Ojcius DM, Arditi M. 2011. Caspase-1 dependent IL-1 beta secretion is critical for host defense in a mouse model of Chlamydia pneumoniae lung infection. PLoS One 6:e21477. http://dx.doi.org/10.1371/journal.pone.0021477.
42. Lima-Junior DS, Costa DL, Carregaro V, Cunha LD, Silva ALN, Mineo TWP, Gutierrez FRS, Bellio M, Bortoluci KR, Flavell RA, Bozza MT, Silva JS, Zamboni DS. 2013. Inflammasome-derived IL-1 beta production induces nitric oxide-mediated resistance to Leishmania. Nat Med 19:909-916. http://dx.doi.org/10.1038/nm.3221.
43. Kostura MJ, Tocci MJ, Limjuco G, Chin J, Cameron P, Hillman AG, Chartrain NA, Schmidt JA. 1989. Identification of a monocyte specific pre-interleukin 1-beta convertase activity. Proc Natl Acad Sci U S A 86:5227-5231. http://dx.doi.org/10.1073/pnas.86.14.5227.
44. Newman ZL, Leppla SH, Moayeri M. 2009. CA-074Me protection against anthrax lethal toxin. Infect Immun 77:4327-4336. http://dx.doi .org/10.1128/IAI.00730-09.
45. Blasi F, Centanni S, Allegra L. 2004. Chlamydia pneumoniae: crossing the barriers? Eur Respir J 23:499-500. http://dx.doi.org/10.1183/09031936.04.00001004.
46. Prebeck S, Kirschning C, Durr S, da Costa C, Donath B, Brand K, Redecke V, Wagner H, Miethke T. 2001. Predominant role of Tolllike receptor 2 versus 4 in Chlamydia pneumoniae-induced activation of dendritic cells. J Immunol 167:3316-3323. http://dx.doi.org/10.4049/jim munol.167.6.3316.
47. Darville T, O'Neill JM, Andrews CW, Nagarajan UM, Stahl L, Ojcius DM. 2003. Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. J Immunol 171:6187-6197. http://dx.doi.org/10.4049/jimmunol.171.11.6187.
48. Bas S, Lief L, Vuillet M, Spenato U, Seya T, Matsumoto M, Gabay C. 2008. The proinflammatory cytokine response to Chlamydia trachomatis elementary bodies in human macrophages is partly mediated by a lipoprotein, the macrophage infectivity potentiator, through TLR2/TLR1/TLR6 and CD14. J Immunol 180:1158-1168. http://dx.doi.org/10.4049/jimmunol.180.2.1158.
49. Erridge C, Pridmore A, Eley A, Stewart J, Poxton IR. 2004. Lipopolysaccharides of Bacteroides fragilis, Chlamydia trachomatis and Pseudomonas aeruginosa signal via Toll-like receptor 2. J Med Microbiol 53:735-740. http://dx.doi.org/10.1099/jmm.0.45598-0.
50. O'Connell CM, Ingalls RR, Andrews CW, Scurlock AM, Darville T. 2007. Plasmid-deficient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease. J Immunol 179:4027-4034. http://dx.doi.org/10.4049/jimmunol.179.6.4027.
51. O'Connell CM, Abdel Rahman YM, Green E, Darville HK, Saira K, Smith B, Darville T, Scurlock AM, Meyer CR, Belland RJ. 2011. Tolllike receptor 2 activation by Chlamydia trachomatis is plasmid dependent, and plasmid-responsive chromosomal loci are coordinately regulated in response to glucose limitation by C. trachomatis but not by C. muridarum. Infect Immun 79:1044-1056. http://dx.doi.org/10.1128/IAI.01118-10.
52. Buchholz KR, Stephens RS. 2006. Activation of the host cell proinflammatory interleukin-8 response by Chlamydia trachomatis. Cell Microbiol 8:1768-1779. http://dx.doi.org/10.1111/j.1462-5822.2006.00747.x.
53. Buchholz KR, Stephens RS. 2007. The extracellular signal-regulated kinase/mitogen-activated protein kinase pathway induces the inflammatory factor interleukin-8 following Chlamydia trachomatis infection. Infect Immun 75:5924-5929. http://dx.doi.org/10.1128/IAI.01029-07.
54. Ramsey KH, Miranpuri GS, Sigar IM, Ouellette S, Byrne GI. 2001. Chlamydia trachomatis persistence in the female mouse genital tract: inducible nitric oxide synthase and infection outcome. Infect Immun 69:5131-5137. http://dx.doi.org/10.1128/IAI.69.8.5131-5137.2001.
55. Wantia N, Rodriguez N, Cirl C, Ertl T, Duerr S, Layland LE, Wagner H, Miethke T. 2011. Toll-like receptors 2 and 4 regulate the frequency of IFN gamma-producing CD4(+) T-cells during pulmonary infection with Chlamydia pneumoniae. PLoS One 6:e26101. http://dx.doi.org/10.1371/journal.pone.0026101.
56. Huang J, DeGraves FJ, Lenz SD, Gao DY, Feng P, Li D, Schlapp T, Kaltenboeck B. 2002. The quantity of nitric oxide released by macrophages regulates Chlamydia induced disease. Proc Natl Acad Sci U S A 99:3914-3919. http://dx.doi.org/10.1073/pnas.062578399.
57. Maxion HK, Liu W, Chang MH, Kelly KA. 2004. The infecting dose of Chlamydia muridarum modulates the innate immune response and ascending infection. Infect Immun 72:6330-6340. http://dx.doi.org/10.1128/IAI.72.11.6330-6340.2004.
58. Tsai HH, Lee WR, Wang PH, Cheng KT, Chen YC, Shen SC. 2013. Propionibacterium acnes-induced iNOS and COX-2 protein expression via ROS-dependent NF-kappa B and AP-1 activation in macrophages. J Dermatol Sci 69:122-131. http://dx.doi.org/10.1016/j.jdermsci.2012.10.009.
59. Wu F, Tyml K, Wilson JX. 2008. iNOS expression requires NADPH oxidase-dependent redox signaling in microvascular endothelial cells. J Cell Physiol 217:207-214. http://dx.doi.org/10.1002/jcp.21495.
60. Boya P, Kroemer G. 2008. Lysosomal membrane permeabilization in cell death. Oncogene 27:6434-6451. http://dx.doi.org/10.1038/onc.2008.310.
61. Heid ME, Keyel PA, Kamga C, Shiva S, Watkins SC, Salter RD. 2013. Mitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activation. J Immunol 191:5230-5238. http://dx.doi.org/10.4049/jimmunol.1301490.
62. Rajaram K, Giebel AM, Toh E, Hu S, Newman JH, Morrison SG, Kari L, Morrison RP, Nelson DE. 2015. Mutational analysis of the Chlamydia muridarum plasticity zone. Infect Immun 83:2870-2881. http://dx.doi .org/10.1128/IAI.00106-15.